Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer

To develop an alternative treatment for lung cancer, a combination of two potent chemotherapeutic agents – liposomal apigenin and tyroservatide – was developed. The therapeutic potential of this combination was investigated using A549 cells. Apigenin and tocopherol derivative-containing D-alpha-toco...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xin, Yang, Qing, Zhang, Youwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522679/
https://www.ncbi.nlm.nih.gov/pubmed/28761344
http://dx.doi.org/10.2147/IJN.S140096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522679/
https://www.ncbi.nlm.nih.gov/pubmed/28761344
http://dx.doi.org/10.2147/IJN.S140096

Ejemplares similares